🇺🇸 FDA
Pipeline program

Mecasermin rinfabate

OHB-607-202

Phase 2 small_molecule active

Quick answer

Mecasermin rinfabate for Chronic Lung Disease is a Phase 2 program (small_molecule) at Ology Bioservices Ireland LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
Ology Bioservices Ireland LTD
Indication
Chronic Lung Disease
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials